分岐ステントグラフトの市場規模、シェア、成長分析、デバイスタイプ別、材料別、用途別、地域別 - 産業予測、2025～2032年

分岐ステントグラフトの世界市場規模は、2023年に3億2,439万米ドルと評価され、2024年の3億4,937万米ドルから2032年には6億3,242万米ドルに成長し、予測期間（2025-2032年）のCAGRは7.7%で成長する見通しです。

分岐型ステントグラフト市場は、当初は大動脈病変の治療用に開発されたが、血管内大動脈修復術（EVAR）の増加や患者ケアの技術進歩により、大きな成長を遂げています。この革新的な治療は、大胸動脈瘤や動脈解離に対するEVARの適用を拡大し、特に高齢化社会における大動脈瘤や腹部動脈瘤の有病率の上昇に対処しています。しかし、COVID-19パンデミックの発生が市場の進展を妨げ、売上の減少や待機的手術の遅れにつながった。このような課題にもかかわらず、低侵襲手術に対する需要の高まりによって市場は回復に向かっており、今後数年間は市場拡大の大きなチャンスとなります。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 規制分析

分岐ステントグラフト市場規模：デバイスタイプ別

• 市場概要
• 大動脈分岐ステントグラフト
• 腸骨分岐ステントグラフト
• 大腿骨分岐ステントグラフト
• 分岐ステントグラフト市場規模：素材別
• 市場概要
• ニチノール
• ポリテトラフルオロエチレン（PTFE）
• ポリエステル

分岐ステントグラフト市場規模：用途別

• 市場概要
• EVAR
• チムニー
• 窓開き型血管内大動脈瘤修復術
• その他

分岐ステントグラフト市場規模

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Medtronic plc
• Cook Medical
• W. L. Gore & Associates, Inc.
• Endologix, Inc.
• JOTEC GmbH
• LeMaitre Vascular, Inc.
• MicroPort Scientific Corporation
• Terumo Corporation
• Vascutek, Ltd.
• Zenith（Cook Medical）
• TriVascular Technologies, Inc.
• Bolton Medical
• Lombard Medical, Inc.
• QualiMed Innovative Medizinprodukte GmbH
• Nano Endoluminal, S.L.

結論と推奨事項

Global Branched Stent Grafts Market size was valued at USD 324.39 Million in 2023 and is poised to grow from USD 349.37 Million in 2024 to USD 632.42 Million by 2032, growing at a CAGR of 7.7% during the forecast period (2025-2032).

The branched stent graft market, initially developed for treating aortic lesions, is experiencing significant growth due to an increasing number of endovascular aortic repair (EVAR) procedures and technological advancements in patient care. This innovative treatment expands EVAR applications for pectoral aneurysms and arterial dissections, addressing the rising prevalence of aortic and abdominal aneurysms, particularly among the aging population. However, the onset of the COVID-19 pandemic hindered market progress, leading to decreased sales and delayed elective surgeries. Despite these challenges, the market is poised for recovery, driven by a growing demand for minimally invasive surgical options, which presents substantial opportunities for market expansion in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Branched Stent Grafts market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Branched Stent Grafts Market Segmental Analysis

Global Branched Stent Grafts Market is segmented by device type, material, application and region. Based on device type, the market is segmented into aortic branched stent grafts, iliac branched stent grafts and femoral branched stent grafts. Based on material, the market is segmented into nitinol, polytetrafluoroethylene (PTFE) and polyester. Based on application, the market is segmented into EVAR, chimney, fenestrated endovascular aortic aneurysm repair and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Branched Stent Grafts Market

The Global Branched Stent Grafts market is experiencing significant growth, primarily driven by the increasing number of endovascular aneurysm repair (EVAR) procedures. This uptick can be attributed to enhancements in patient care quality and continual advancements in medical technology, which improve procedural outcomes. Additionally, the ageing population is a crucial factor contributing to market expansion, as older individuals are more susceptible to health issues such as abdominal aortic aneurysms (AAA). Consequently, the combination of these elements is fostering a conducive environment for the continued development and adoption of branched stent grafts within the healthcare landscape.

Restraints in the Global Branched Stent Grafts Market

The Global Branched Stent Grafts market faces significant challenges due to high costs associated with endovascular aneurysm repair procedures. These expenses often render such treatments unaffordable for middle- and lower-income individuals, limiting their access to vital medical interventions. As a result, the financial burden acts as a major restraint on the growth of the branched stent grafts market, as many potential patients may opt for alternative, less costly options or forego treatment altogether. This financial barrier ultimately impacts market demand and hinders the overall expansion of branched stent graft technologies within the healthcare landscape.

Market Trends of the Global Branched Stent Grafts Market

The Global Branched Stent Grafts market is witnessing significant growth driven by the increasing adoption of minimally invasive procedures like AEVAR, BEVAR, and TEVAR for aneurysm treatment. These advanced techniques offer patients safety, efficacy, and cost-effectiveness, appealing to both healthcare providers and patients alike. The demand for Image guidance technologies, such as X-rays, further enhances procedural success, solidifying branched stent grafts as essential tools in vascular interventions. As awareness of vascular diseases grows and technology advances, the market for branched stent grafts is poised for expansion, making it a key area of investment for medical device manufacturers and healthcare providers globally.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis

Global Branched Stent Grafts Market Size by Device Type & CAGR (2025-2032)

• Market Overview
• Aortic Branched Stent Grafts
• Iliac Branched Stent Grafts
• Femoral Branched Stent Grafts
• Global Branched Stent Grafts Market Size by Material & CAGR (2025-2032)
• Market Overview
• Nitinol
• Polytetrafluoroethylene (PTFE)
• Polyester

Global Branched Stent Grafts Market Size by Application & CAGR (2025-2032)

• Market Overview
• EVAR
• Chimney
• Fenestrated Endovascular Aortic Aneurysm Repair
• Others

Global Branched Stent Grafts Market Size & CAGR (2025-2032)

• North America (Device Type, Material, Application)
  • US
  • Canada
• Europe (Device Type, Material, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Device Type, Material, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Device Type, Material, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Device Type, Material, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Medtronic plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• W. L. Gore & Associates, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Endologix, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• JOTEC GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LeMaitre Vascular, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroPort Scientific Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vascutek, Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zenith (Cook Medical)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TriVascular Technologies, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bolton Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lombard Medical, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QualiMed Innovative Medizinprodukte GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nano Endoluminal, S.L.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations